Site icon OncologyTube

Debate: Optimal adjuvant chemotherapy for resected pancreatic cancer – Gemcitabine/nab-paclitaxel

In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Jordan Berlin argues that gemcitabine/nab-paclitaxel is the optimal adjuvant chemotherapy for resected pancreatic cancer.

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GICANCER

© 2017 Imedex, LLC.

Advertisement
Exit mobile version